William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories
-
Saratoga Investment prices $85M in notes due 2031 at 8.00%
-
Saratoga Investment prices $85M in notes due 2031 at 8.00%
-
Arxis completes $770M acquisition of Omnetics Connector
-
Saratoga Investment Corp. launches unsecured notes offering on NYSE
-
William Blair Starts Enliven Therapeutics (ELVN) at Outperform
-
Andersen Group launches secondary offering of 4.28M shares
-
Form N-PX WILLIAM BLAIR FUNDS For: Jun 30
-
Form N-PX WILLIAM BLAIR INVESTMENT For: Jun 30
-
William Blair Downgrades Enovix Corporation (ENVX) to Market Perform
-
Silence Therapeutics closes $201M public offering of ADSs
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
KKR prices secondary offering of 5 million BridgeBio shares
-
KKR to sell 5 million BridgeBio shares in secondary offering
-
Savers Value Village closes 23M share secondary offering
-
William Blair Downgrades Accelerant Holdings (ARX) to Market Perform
-
Form 13F-HR WILLIAM BLAIR INVESTMENT For: Jun 30
-
William Blair Downgrades Cardiff Oncology (CRDF) to Market Perform
-
Silence Therapeutics prices $175 million public offering at $13.50 per ADS
-
Savers Value Village prices $205M secondary stock offering
-
Form SCHEDULE 13G Revolve Group, Inc. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G/A Twist Bioscience Corp Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G/A i3 Verticals, Inc. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
William Blair Downgrades On Holding AG (ONON) to Market Perform
-
Form 13F-HR BLAIR WILLIAM & CO/IL For: Jun 30
-
William Blair Assumes Applied Materials (AMAT) at Market Perform
-
On Holding Q2 seen holding strong as spending data counters July search slowdown
-
Silence Therapeutics launches $150 million ADS public offering
-
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
-
William Blair Downgrades Tenax Therapeutics (TENX) to Market Perform
-
Lyntris launches IPO at $19-$22 per share on NYSE
-
Lyntris Inc. Announces Launch of its Initial Public Offering
-
William Blair Starts Standard Nuclear (STDN) at Outperform

